A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation-Reference-Cited by-同舟云学术

A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation

Published:2015-11 Issue: Volume:69 Page:22-29
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Ali Mohammed T.^ORCID,Martin Kenneth,Kumar Arun H.S.,Cavallin Erika,Pierrou Stefan,Gleeson Birgitta M.,McPheat William L.,Turner Elizebeth C.,Huang Chien-Ling,Khider Wisam,Vaughan Carl,Caplice Noel M.

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference41 articles.

1. In-stent restenosis in the drug-eluting stent era;Dangas;J. Am. Coll. Cardiol.,2010

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N. Engl. J. Med.,2003

3. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies;Kirtane;Circulation,2009

4. The examination trial (everolimus-eluting stents versus bare-metal stents in st-segment elevation myocardial infarction): 2-year results from a multicenter randomized controlled trial;Sabate;JACC Cardiovasc. Interv.,2014

5. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography;Cassese;Heart,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asiatic acid alleviates vascular remodeling in BAPN‐induced aortic dissection through inhibiting NF‐κB p65/CX3CL1 signaling;The FASEB Journal;2024-05-04

2. Targeting immune cell recruitment in atherosclerosis;Nature Reviews Cardiology;2024-04-25

3. Deciphering the role of CX3CL1-CX3CR1 in aortic aneurysm pathogenesis: insights from Mendelian randomization and transcriptomic analyses;Frontiers in Immunology;2024-04-23

4. Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease—Is There a Link?;International Journal of Molecular Sciences;2024-03-30

5. Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease;Journal of Clinical Medicine;2023-07-21